Cargando…
Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation
Candida albicans, an opportunistic fungal pathogen, frequently colonizes immune-compromised patients and causes mild to severe systemic reactions. Only few antifungal drugs are currently in use for therapeutic treatment. However, evolution of a drug-resistant C. albicans fungal pathogen is of major...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124935/ https://www.ncbi.nlm.nih.gov/pubmed/34066433 http://dx.doi.org/10.3390/molecules26092722 |
_version_ | 1783693353569746944 |
---|---|
author | Uppar, Vijayakumar Chandrashekharappa, Sandeep Shivamallu, Chandan P, Sushma Kollur, Shiva Prasad Ortega-Castro, Joaquín Frau, Juan Flores-Holguín, Norma Basarikatti, Atiyaparveen I. Chougala, Mallikarjun Mohan M, Mrudula Banuprakash, Govindappa Jayadev, Venugopala, Katharigatta N. Nandeshwarappa, Belakatte P. Veerapur, Ravindra Al-Kheraif, Abdulaziz A. Elgorban, Abdallah M. Syed, Asad Mudnakudu-Nagaraju, Kiran K. Padmashali, Basavaraj Glossman-Mitnik, Daniel |
author_facet | Uppar, Vijayakumar Chandrashekharappa, Sandeep Shivamallu, Chandan P, Sushma Kollur, Shiva Prasad Ortega-Castro, Joaquín Frau, Juan Flores-Holguín, Norma Basarikatti, Atiyaparveen I. Chougala, Mallikarjun Mohan M, Mrudula Banuprakash, Govindappa Jayadev, Venugopala, Katharigatta N. Nandeshwarappa, Belakatte P. Veerapur, Ravindra Al-Kheraif, Abdulaziz A. Elgorban, Abdallah M. Syed, Asad Mudnakudu-Nagaraju, Kiran K. Padmashali, Basavaraj Glossman-Mitnik, Daniel |
author_sort | Uppar, Vijayakumar |
collection | PubMed |
description | Candida albicans, an opportunistic fungal pathogen, frequently colonizes immune-compromised patients and causes mild to severe systemic reactions. Only few antifungal drugs are currently in use for therapeutic treatment. However, evolution of a drug-resistant C. albicans fungal pathogen is of major concern in the treatment of patients, hence the clinical need for novel drug design and development. In this study, in vitro screening of novel putative pyrrolo[1,2-a]quinoline derivatives as the lead drug targets and in silico prediction of the binding potential of these lead molecules against C. albicans pathogenic proteins, such as secreted aspartic protease 3 (SAP3; 2H6T), surface protein β-glucanase (3N9K) and sterol 14-alpha demethylase (5TZ1), were carried out by molecular docking analyses. Further, biological activity-based QSAR and theoretical pharmacokinetic analysis were analyzed. Here, in vitro screening of novel analogue derivatives as drug targets against C. albicans showed inhibitory potential in the concentration of 0.4 µg for BQ-06, 07 and 08, 0.8 µg for BQ-01, 03, and 05, 1.6 µg for BQ-04 and 12.5 µg for BQ-02 in comparison to the standard antifungal drug fluconazole in the concentration of 30 µg. Further, in silico analysis of BQ-01, 03, 05 and 07 analogues docked on chimeric 2H6T, 3N9K and 5TZ1 revealed that these analogues show potential binding affinity, which is different from the therapeutic antifungal drug fluconazole. In addition, these molecules possess good drug-like properties based on the determination of conceptual Density Functional Theory (DFT)-based descriptors, QSAR and pharmacokinetics. Thus, the study offers significant insight into employing pyrrolo[1,2-a]quinoline analogues as novel antifungal agents against C. albicans that warrants further investigation. |
format | Online Article Text |
id | pubmed-8124935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81249352021-05-17 Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation Uppar, Vijayakumar Chandrashekharappa, Sandeep Shivamallu, Chandan P, Sushma Kollur, Shiva Prasad Ortega-Castro, Joaquín Frau, Juan Flores-Holguín, Norma Basarikatti, Atiyaparveen I. Chougala, Mallikarjun Mohan M, Mrudula Banuprakash, Govindappa Jayadev, Venugopala, Katharigatta N. Nandeshwarappa, Belakatte P. Veerapur, Ravindra Al-Kheraif, Abdulaziz A. Elgorban, Abdallah M. Syed, Asad Mudnakudu-Nagaraju, Kiran K. Padmashali, Basavaraj Glossman-Mitnik, Daniel Molecules Article Candida albicans, an opportunistic fungal pathogen, frequently colonizes immune-compromised patients and causes mild to severe systemic reactions. Only few antifungal drugs are currently in use for therapeutic treatment. However, evolution of a drug-resistant C. albicans fungal pathogen is of major concern in the treatment of patients, hence the clinical need for novel drug design and development. In this study, in vitro screening of novel putative pyrrolo[1,2-a]quinoline derivatives as the lead drug targets and in silico prediction of the binding potential of these lead molecules against C. albicans pathogenic proteins, such as secreted aspartic protease 3 (SAP3; 2H6T), surface protein β-glucanase (3N9K) and sterol 14-alpha demethylase (5TZ1), were carried out by molecular docking analyses. Further, biological activity-based QSAR and theoretical pharmacokinetic analysis were analyzed. Here, in vitro screening of novel analogue derivatives as drug targets against C. albicans showed inhibitory potential in the concentration of 0.4 µg for BQ-06, 07 and 08, 0.8 µg for BQ-01, 03, and 05, 1.6 µg for BQ-04 and 12.5 µg for BQ-02 in comparison to the standard antifungal drug fluconazole in the concentration of 30 µg. Further, in silico analysis of BQ-01, 03, 05 and 07 analogues docked on chimeric 2H6T, 3N9K and 5TZ1 revealed that these analogues show potential binding affinity, which is different from the therapeutic antifungal drug fluconazole. In addition, these molecules possess good drug-like properties based on the determination of conceptual Density Functional Theory (DFT)-based descriptors, QSAR and pharmacokinetics. Thus, the study offers significant insight into employing pyrrolo[1,2-a]quinoline analogues as novel antifungal agents against C. albicans that warrants further investigation. MDPI 2021-05-06 /pmc/articles/PMC8124935/ /pubmed/34066433 http://dx.doi.org/10.3390/molecules26092722 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Uppar, Vijayakumar Chandrashekharappa, Sandeep Shivamallu, Chandan P, Sushma Kollur, Shiva Prasad Ortega-Castro, Joaquín Frau, Juan Flores-Holguín, Norma Basarikatti, Atiyaparveen I. Chougala, Mallikarjun Mohan M, Mrudula Banuprakash, Govindappa Jayadev, Venugopala, Katharigatta N. Nandeshwarappa, Belakatte P. Veerapur, Ravindra Al-Kheraif, Abdulaziz A. Elgorban, Abdallah M. Syed, Asad Mudnakudu-Nagaraju, Kiran K. Padmashali, Basavaraj Glossman-Mitnik, Daniel Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation |
title | Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation |
title_full | Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation |
title_fullStr | Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation |
title_full_unstemmed | Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation |
title_short | Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation |
title_sort | investigation of antifungal properties of synthetic dimethyl-4-bromo-1-(substituted benzoyl) pyrrolo[1,2-a] quinoline-2,3-dicarboxylates analogues: molecular docking studies and conceptual dft-based chemical reactivity descriptors and pharmacokinetics evaluation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124935/ https://www.ncbi.nlm.nih.gov/pubmed/34066433 http://dx.doi.org/10.3390/molecules26092722 |
work_keys_str_mv | AT upparvijayakumar investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT chandrashekharappasandeep investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT shivamalluchandan investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT psushma investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT kollurshivaprasad investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT ortegacastrojoaquin investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT fraujuan investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT floresholguinnorma investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT basarikattiatiyaparveeni investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT chougalamallikarjun investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT mohanmmrudula investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT banuprakashgovindappa investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT jayadev investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT venugopalakatharigattan investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT nandeshwarappabelakattep investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT veerapurravindra investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT alkheraifabdulaziza investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT elgorbanabdallahm investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT syedasad investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT mudnakudunagarajukirank investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT padmashalibasavaraj investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation AT glossmanmitnikdaniel investigationofantifungalpropertiesofsyntheticdimethyl4bromo1substitutedbenzoylpyrrolo12aquinoline23dicarboxylatesanaloguesmoleculardockingstudiesandconceptualdftbasedchemicalreactivitydescriptorsandpharmacokineticsevaluation |